miRNA Tools Lead Development of Next-Generation Therapeutics and Diagnostics

miRNA Tools Lead Development of Next-Generation Therapeutics and Diagnostics

Although microRNAs (miRNAs) represent only a small fraction of the total RNA mass in a given sample - estimated at about 0.01% - the short RNA molecules (16-35 nucleotides) are widely viewed as a rich analytical resource for biomarkers and drug targets. miRNAs are believed to be involved in the regulation of more than 30% of protein-coding human genes through a complex regulatory network. Through broad gene regulation activity, miRNAs influence a range of cell processes and consequently play rol...


qPCR? dPCR? From Anywhere? They’ve Got an App for That in Infectious Disease Testing

qPCR? dPCR? From Anywhere? They’ve Got an App for That in Infectious Disease Testing

This blog post reviews molecular point-of-care (POC) diagnostic platforms included in the most recent edition of the report The Market and Potential for Molecular Point of Care Diagnostics. Kalorama Information offers related titles with qPCR and dPCR Markets , The World Market for Infectious Disease Diagnostic Tests , and The World Market for Molecular Diagnostics.

Contributing a high amount of growth to the clinical IVD market over the past decade, molecular diagnostics is established in ref...